Publication Name	World Journal of Gastroenterology
Manuscript ID	65736
Country	Germany

Received	2021-03-16 18:24
Peer-Review Started	2021-03-16 19:03
To Make the First Decision
Return for Revision	2021-05-01 04:46
Revised	2021-05-13 11:40
Second Decision	2021-08-30 03:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-30 09:11
Articles in Press	2021-08-30 09:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-09-13 00:45
Publish the Manuscript Online	2021-09-15 10:33

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Opinion Review
Article Title	Screening for nonalcoholic fatty liver disease-when, who and how?
Manuscript Source	Invited Manuscript
All Author List	Christoph G Dietrich, Monika Rau and Andreas Geier
ORCID	Author(s) ORCID Number Christoph G Dietrich http://orcid.org/0000-0001-6927-7970 Monika Rau http://orcid.org/0000-0003-1219-4044 Andreas Geier http://orcid.org/0000-0002-9626-5083
Funding Agency and Grant Number
Corresponding Author	Christoph G Dietrich, MD, PhD, Chief Doctor, Department of Internal Medicine, Bethlehem Health Center, Steinfeldstr. 5, Stolberg 52222, Germany. christoph.g.dietrich@googlemail.com
Key Words	Screening; Nonalcoholic fatty liver disease; Diabetes; Liver fibrosis; Cirrhosis
Core Tip	Nonalcoholic fatty liver disease (NAFLD) is becoming more important in Western countries and leads to serious complications in patients with progressive disease. The epidemiological, clinical and technical requirements for screening for this disease are fulfilled and are outlaid in this review. It is time to consider a screening program for NAFLD.
Publish Date	2021-09-15 10:33
Citation	Dietrich CG, Rau M, Geier A. Screening for nonalcoholic fatty liver disease-when, who and how? World J Gastroenterol 2021; 27(35): 5803-5821
URL	https://www.wjgnet.com/1007-9327/full/v27/i35/5803.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i35.5803

Full Article (PDF)	WJG-27-5803.pdf
Full Article (Word)	WJG-27-5803.docx
Manuscript File	65736_Auto_Edited-JLW.docx
Answering Reviewers	65736-Answering reviewers.pdf
Audio Core Tip	65736-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	65736-Conflict-of-interest statement.pdf
Copyright License Agreement	65736-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	65736-Language certificate.pdf
Peer-review Report	65736-Peer-review(s).pdf
Scientific Misconduct Check	65736-Scientific misconduct check.pdf
Scientific Editor Work List	65736-Scientific editor work list.pdf
CrossCheck Report	65736-CrossCheck report.pdf